BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 19618609)

  • 1. Clinical value of whole-body magnetic resonance diffusion weighted imaging on detection of malignant metastases.
    Li C; Liu ZS; Du XM; He L; Chen J; Wang W; Sun F; Du F; Luo ZG; Xue ZL; Zhao Y; Zhou CW
    Chin Med Sci J; 2009 Jun; 24(2):112-6. PubMed ID: 19618609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
    Chen W; Jian W; Li HT; Li C; Zhang YK; Xie B; Zhou DQ; Dai YM; Lin Y; Lu M; Huang XQ; Xu CX; Chen L
    Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of Whole-Body DWI for Metastases Screening in a Diverse Group of Malignancies: Comparison With Conventional Cross-Sectional Imaging and Nuclear Scintigraphy.
    Paruthikunnan SM; Kadavigere R; Karegowda LH
    AJR Am J Roentgenol; 2017 Sep; 209(3):477-490. PubMed ID: 28678578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of whole-body diffusion-weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms.
    Akay S; Kocaoglu M; Emer O; Battal B; Arslan N
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):274-82. PubMed ID: 23721135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of whole-body diffusion-weighted MRI (WB-DWI/MRI) in diagnosis, staging and follow-up of gastric cancer, in comparison to CT: a pilot study.
    De Vuysere S; Vandecaveye V; De Bruecker Y; Carton S; Vermeiren K; Tollens T; De Keyzer F; Dresen RC
    BMC Med Imaging; 2021 Feb; 21(1):18. PubMed ID: 33546626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study.
    Han SN; Amant F; Michielsen K; De Keyzer F; Fieuws S; Van Calsteren K; Dresen RC; Gziri MM; Vandecaveye V
    Eur Radiol; 2018 May; 28(5):1862-1874. PubMed ID: 29218610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Feasibility and clinical value of whole body diffusion weighted magnetic resonance imaging in detection of bone metastases].
    Li S; Xue HD; Sun F; Jin ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):192-9. PubMed ID: 19507599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body diffusion-weighted imaging: is it all we need for detecting metastases in melanoma patients?
    Petralia G; Padhani A; Summers P; Alessi S; Raimondi S; Testori A; Bellomi M
    Eur Radiol; 2013 Dec; 23(12):3466-76. PubMed ID: 23884300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Value of Whole-Body DWI With Background Body Suppression Plus Calculation of Apparent Diffusion Coefficient at 3 T Versus
    Sun W; Li M; Gu Y; Sun Z; Qiu Z; Zhou Y
    AJR Am J Roentgenol; 2020 Feb; 214(2):446-454. PubMed ID: 31799866
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy.
    Takano A; Oriuchi N; Tsushima Y; Taketomi-Takahashi A; Nakajima T; Arisaka Y; Higuchi T; Amanuma M; Endo K
    Ann Nucl Med; 2008 Jun; 22(5):395-401. PubMed ID: 18600417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images.
    Nakanishi K; Kobayashi M; Nakaguchi K; Kyakuno M; Hashimoto N; Onishi H; Maeda N; Nakata S; Kuwabara M; Murakami T; Nakamura H
    Magn Reson Med Sci; 2007; 6(3):147-55. PubMed ID: 18037795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole body MRI, including diffusion-weighted imaging in follow-up of patients with testicular cancer.
    Mosavi F; Laurell A; Ahlström H
    Acta Oncol; 2015 Nov; 54(10):1763-9. PubMed ID: 25975210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-body MRI for metastases screening: a preliminary study using 3D VIBE sequences with automatic subtraction between noncontrast and contrast enhanced images.
    Thomson V; Pialat JB; Gay F; Coulon A; Voloch A; Granier A; Guérin JC; Viallon M; Berthezene Y
    Am J Clin Oncol; 2008 Jun; 31(3):285-92. PubMed ID: 18525309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of whole body diffusion weighted MR imaging for diagnosis and staging of malignant lymphoma.
    Li S; Xue HD; Li J; Sun F; Jiang B; Liu D; Sun HY; Jin ZY
    Chin Med Sci J; 2008 Sep; 23(3):138-44. PubMed ID: 18853847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis.
    Li B; Li Q; Nie W; Liu S
    Eur J Radiol; 2014 Feb; 83(2):338-44. PubMed ID: 24355655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of whole body diffusion weighted imaging for screening primary tumors of patients with metastases.
    Gu TF; Xiao XL; Sun F; Yin JH; Zhao H
    Chin Med Sci J; 2008 Sep; 23(3):145-50. PubMed ID: 18853848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI.
    Eiber M; Holzapfel K; Ganter C; Epple K; Metz S; Geinitz H; Kübler H; Gaa J; Rummeny EJ; Beer AJ
    J Magn Reson Imaging; 2011 May; 33(5):1160-70. PubMed ID: 21509875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary application of whole body diffusion weighted imaging in screening metastasis.
    Guan YJ; Ling HW; Chen KM
    Chin Med Sci J; 2008 Sep; 23(3):178-82. PubMed ID: 18853854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shortening the acquisition time of whole-body MRI: 3D T1 gradient echo Dixon vs fast spin echo for metastatic screening in prostate cancer.
    Lecouvet FE; Pasoglou V; Van Nieuwenhove S; Van Haver T; de Broqueville Q; Denolin V; Triqueneaux P; Tombal B; Michoux N
    Eur Radiol; 2020 Jun; 30(6):3083-3093. PubMed ID: 32065282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of
    Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.